相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity
Andrew C. Nelson et al.
MODERN PATHOLOGY (2018)
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
John H. Strickler et al.
CANCER DISCOVERY (2018)
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
Troels Dreier Christensen et al.
ACTA ONCOLOGICA (2018)
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
J. B. Bachet et al.
ANNALS OF ONCOLOGY (2018)
European cancer mortality predictions for the year 2018 with focus on colorectal cancer
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2018)
Emergence of KRAS mutation may play a major role in the secondary resistance to EGFR blockade
T. Yamada et al.
ANNALS OF ONCOLOGY (2018)
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
C. Cremolini et al.
ANNALS OF ONCOLOGY (2018)
Colorectal cancer liver metastases - a population-based study on incidence, management and survival
Jennie Engstrand et al.
BMC CANCER (2018)
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing
M. B. Mogensen et al.
BMC CANCER (2018)
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER CELL (2018)
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
Janneke F. Linnekamp et al.
CELL DEATH AND DIFFERENTIATION (2018)
Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer
Hiroyasu Furuki et al.
EJSO (2018)
Intratumoral morphological heterogeneity can be an indicator of genetic heterogeneity in colorectal cancer
Juliane Buettner et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
Shuji Ogino et al.
GUT (2018)
Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer
Xin Li et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The role of exosomes on colorectal cancer: A review
Lidia Ruiz-Lopez et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Consensus molecular subtype classification of colorectal adenomas
Malgorzata A. Komor et al.
JOURNAL OF PATHOLOGY (2018)
Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice
Tindaro Giardina et al.
PATHOLOGY (2018)
Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience
Nicky D’Haene et al.
Oncotarget (2018)
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology
Shuji Ogino et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Ivana Bratic Hench et al.
FRONTIERS IN MEDICINE (2018)
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S. Siena et al.
ANNALS OF ONCOLOGY (2018)
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial
N. Normanno et al.
ANNALS OF ONCOLOGY (2018)
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
Filippo Pietrantonio et al.
CLINICAL CANCER RESEARCH (2017)
Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer
Yuka Suzuki et al.
MOLECULAR ONCOLOGY (2017)
High concordance rate of KRAS/BRAF mutations. and MSI-H between primary colorectal cancer and corresponding metastases
Kenji Fujiyoshi et al.
ONCOLOGY REPORTS (2017)
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
Sebastian Stintzing et al.
EUROPEAN JOURNAL OF CANCER (2017)
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors
Giuseppe Aprile et al.
FUTURE ONCOLOGY (2017)
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer
Luca Reggiani Bonetti et al.
HUMAN PATHOLOGY (2017)
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
Paola Ulivi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing
Wolff Schmiegel et al.
MOLECULAR ONCOLOGY (2017)
Origins of lymphatic and distant metastases in human colorectal cancer
Kamila Naxerova et al.
SCIENCE (2017)
Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers
Britta Kleist et al.
TUMOR BIOLOGY (2017)
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Huw Geraint Jones et al.
WORLD JOURNAL OF SURGERY (2017)
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population
Yi-Xin Hao et al.
ONCOLOGY LETTERS (2017)
Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
Shiyu Jia et al.
ONCOTARGET (2017)
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu-Pyo Kim et al.
CANCER RESEARCH AND TREATMENT (2017)
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
Jesper Bertram Bramsen et al.
CELL REPORTS (2017)
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution
Subramanian Venkatesan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials
Sabine Tejpar et al.
JAMA ONCOLOGY (2017)
Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing
Weihua Li et al.
CANCER LETTERS (2017)
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
A. R. Thierry et al.
ANNALS OF ONCOLOGY (2017)
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
J. Vidal et al.
ANNALS OF ONCOLOGY (2017)
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
J. Grasselli et al.
ANNALS OF ONCOLOGY (2017)
KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Yuurin Kondo et al.
BMC CANCER (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Noemi Andor et al.
NATURE MEDICINE (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang
Adriana Amaro et al.
CANCER AND METASTASIS REVIEWS (2016)
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing
Valentina Kovaleva et al.
MOLECULAR CANCER (2016)
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
Jerome Alexandre Denis et al.
MOLECULAR ONCOLOGY (2016)
Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases
Nick Beije et al.
MOLECULAR ONCOLOGY (2016)
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Roberto Moretto et al.
ONCOLOGIST (2016)
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
Pedro M. Enriquez-Navas et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection
Anita Sveen et al.
PLOS GENETICS (2016)
Patterns of metastasis in colon and rectal cancer
Matias Riihimaki et al.
SCIENTIFIC REPORTS (2016)
High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
Marion Jeantet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: Identification of driver and passenger mutations
Stijn Crobach et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M. P. Morelli et al.
ANNALS OF ONCOLOGY (2015)
Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
Marcilei E. C. Buim et al.
CANCER BIOLOGY & THERAPY (2015)
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy
Karen-Lise Garm Spindler et al.
EUROPEAN JOURNAL OF CANCER (2015)
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva et al.
NATURE GENETICS (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
Richard Kim et al.
PLOS ONE (2015)
High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer
Iain Beehuat Tan et al.
GENOME BIOLOGY (2015)
Immune checkpoints and immunotherapy for colorectal cancer
Preet Paul Singh et al.
GASTROENTEROLOGY REPORT (2015)
Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases
Chen Mao et al.
SCIENTIFIC REPORTS (2015)
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E. Missiaglia et al.
ANNALS OF ONCOLOGY (2014)
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Alain R. Thierry et al.
NATURE MEDICINE (2014)
Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers
Sun Young Lee et al.
PLOS ONE (2014)
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
Sandra Misale et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
A. Rose Brannon et al.
GENOME BIOLOGY (2014)
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
M. K. Boisen et al.
ANNALS OF ONCOLOGY (2013)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
Francesco Fabbri et al.
CANCER LETTERS (2013)
Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
Christin Gasch et al.
CLINICAL CHEMISTRY (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Incidence and prognosis of synchronous colorectal carcinomatosis
Diane Goere et al.
FUTURE ONCOLOGY (2013)
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso et al.
SCIENCE (2013)
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Tomoya Yokota
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
Mi-Jung Kim et al.
BMC CANCER (2012)
Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment
Joost S. Vermaat et al.
CLINICAL CANCER RESEARCH (2012)
Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Karen-Lise Garm Spindler et al.
CLINICAL CANCER RESEARCH (2012)
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
Efsevia Vakiani et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
N. Knijn et al.
BRITISH JOURNAL OF CANCER (2011)
Heterogeneity of KRAS Status May Explain the Subset of Discordant KRAS Status Between Primary and Metastatic Colorectal Cancer
Toshiaki Watanabe et al.
DISEASES OF THE COLON & RECTUM (2011)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study
Valery E. Lemmens et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review
Jara M. Baas et al.
ONCOLOGIST (2011)
Molecular morphometric analysis shows relative intra-tumoural homogeneity for KRAS mutations in colorectal cancer
Liora Farber et al.
VIRCHOWS ARCHIV (2011)
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
Emmanuel Mitry et al.
GUT (2010)
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
Pierre Laurent-Puig et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genomic and epigenetic instability in colorectal cancer pathogenesis
William M. Grady et al.
GASTROENTEROLOGY (2008)
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer
Salvatore Artale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Epidemiology and management of liver metastases from colorectal cancer
Sylvain Manfredi et al.
ANNALS OF SURGERY (2006)
Guidelines for resection of colorectal cancer liver metastases
O. J. Garden et al.
GUT (2006)
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression
L Losi et al.
CARCINOGENESIS (2005)
Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases?
R Adam et al.
ANNALS OF SURGERY (2004)
Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma
B Baisse et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer
S Tórtola et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
